Fibronostics: Fibronostics Secures Financing, Announces New CEO
Fibronostics , a global leader in non-invasive, AI-driven diagnostics for NASH patients, announced today it has secured $6.5 million in funding.
Read full article »
Fibronostics is a Florida-based SaaS platform that provides solutions such as liver health diagnosis, screening and monitoring for the healthcare industry.
Read more